CATX - Perspective Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Perspective Therapeutics, Inc.
IPO Date: May 31, 2002
Sector: Healthcare
Industry: Medical Devices
Market Cap: $328.76M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 4.57%
Avg Daily Range (30 D): $0.08 | 2.63%
Avg Daily Range (90 D): $0.10 | 2.99%
Institutional Daily Volume
Avg Daily Volume: 1.56M
Avg Daily Volume (30 D): 1.16M
Avg Daily Volume (90 D): 1.33M
Trade Size
Avg Trade Size (Sh.): 191
Avg Trade Size (Sh.) (30 D): 126
Avg Trade Size (Sh.) (90 D): 130
Institutional Trades
Total Institutional Trades: 321
Avg Institutional Trade: $1.71M
Avg Institutional Trade (30 D): $3.01M
Avg Institutional Trade (90 D): $2.77M
Avg Institutional Trade Volume: .49M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.18M
Avg Closing Trade (30 D): $5.25M
Avg Closing Trade (90 D): $3.32M
Avg Closing Volume: 525.88K
 
News
May 21, 2026 @ 9:51 PM
Perspective Therapeutics to Present Data from All ...
Source: Perspective Therapeutics, Inc.
Apr 20, 2026 @ 5:00 PM
Pheochromocytoma and Paraganglioma Market to Exhib...
Source: Delveinsight
Apr 20, 2026 @ 10:00 AM
Perspective Therapeutics Presents Updated Interim ...
Source: Perspective Therapeutics, Inc.
Apr 2, 2026 @ 11:00 AM
Perspective Therapeutics to Participate in Upcomin...
Source: Not Specified
Feb 17, 2026 @ 4:17 PM
New Treatment Modalities Are Reaching Cancers That...
Source: Prnewswire
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.22 $-.25
Diluted EPS $-.22 $-.25
Revenue $.08M $.08M
Gross Profit
Net Income / Loss $-26.79M $-26.19M
Operating Income / Loss $-29.26M $-28.28M
Cost of Revenue
Net Cash Flow $-5.48M $23.34M
PE Ratio    
Splits
Jun 17, 2024 1:10